These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21488364)

  • 1. [Ukrainian break-through in the European and world strategy of individual prophylaxis of ischemic stroke in patients with arterial hypertension].
    Tolstopiatov SM
    Lik Sprava; 2010; (5-6):3-21. PubMed ID: 21488364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pilote strategy to optimize an individual treatment of arterial hypertention and algorithm of the prophylactics of vascular complications].
    Tolstopiatov SM
    Lik Sprava; 2006 Dec; (8):21-34. PubMed ID: 17427421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimization of the treatment and prevention of thrombus formation in arterial hypertension].
    Tolstopiatov SM; Naumenko LE
    Lik Sprava; 2007; (7):60-7. PubMed ID: 18663939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation between biomarkers of the coagulation cascade, fibrinolytic system and lipid profiles in hypertensive patients with various coagulation potential of whole blood].
    Tolstopiatov SM
    Lik Sprava; 2009; (7-8):32-40. PubMed ID: 20455445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Module of hypercoagulation as a biomarker for estimation of hemostasis risk factor of thrombosis, determination of an individual antiaggregant dose and the way of its use in patients with arterial hypertension].
    Tolstopiatov SM
    Lik Sprava; 2007; (8):47-60. PubMed ID: 18712096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic stroke in patients receiving aspirin.
    Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of clot formation and improvement of blood rheological properties during microsurgical operations. Part II. Comparative studies of small doses of acelysin and low molecular weight heparin enoxaparine (clexane)].
    Vabishchevich AV; Smirnova LA; Roĭtman EV; Fedotov SA; Shibaev EIu; Svetlov VA
    Anesteziol Reanimatol; 2002; (5):72-6. PubMed ID: 12611307
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient ischemic attack: Part II. Risk factor modification and treatment.
    Simmons BB; Gadegbeku AB; Cirignano B
    Am Fam Physician; 2012 Sep; 86(6):527-32. PubMed ID: 23062044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.
    Lafeber M; Spiering W; van der Graaf Y; Nathoe H; Bots ML; Grobbee DE; Visseren FL
    Am Heart J; 2013 Aug; 166(2):282-289.e1. PubMed ID: 23895811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey.
    Heuschmann PU; Kircher J; Nowe T; Dittrich R; Reiner Z; Cifkova R; Malojcic B; Mayer O; Bruthans J; Wloch-Kopec D; Prugger C; Heidrich J; Keil U
    Eur J Prev Cardiol; 2015 Oct; 22(10):1354-62. PubMed ID: 25139770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal effects of available drugs for ischemic stroke.
    Chen M; Selim M
    Drugs Today (Barc); 2005 Jun; 41(6):401-9. PubMed ID: 16110347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.
    Rothwell PM; Algra A; Amarenco P
    Lancet; 2011 May; 377(9778):1681-92. PubMed ID: 21571151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease prevention using fixed dose pharmacotherapy in Iran: updated meta-analyses and mortality estimation.
    Sepanlou SG; Farzadfar F; Jafari E; Danaei G
    Arch Iran Med; 2012 Sep; 15(9):531-7. PubMed ID: 22924369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
    Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
    Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking trends in secondary stroke prevention strategies.
    Carswell JL; Beard KA; Chevrette MM; Pardue CN; Hess DC; Fagan SC
    Ann Pharmacother; 2004 Feb; 38(2):215-9. PubMed ID: 14742753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary stroke and its prevention in patients with arterial hypertension].
    Parfenov VA; Gurak SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; (Suppl 14):3-7. PubMed ID: 16184847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the European and Japanese guidelines for the management of ischemic stroke.
    Kern R; Nagayama M; Toyoda K; Steiner T; Hennerici MG; Shinohara Y
    Cerebrovasc Dis; 2013; 35(5):402-18. PubMed ID: 23712178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.